Jonathan J Chipman1, Martin G Sanda2, Rodney L Dunn3, John T Wei3, Mark S Litwin4, Catrina M Crociani5, Meredith M Regan6, Peter Chang7. 1. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2. Department of Urology, Emory University, Atlanta, Georgia. 3. Department of Urology, University of Michigan School of Medicine, Ann Arbor, Michigan. 4. David Geffen School of Medicine and Fielding School of Public Health, University of California-Los Angeles, Los Angeles, California. 5. Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 6. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. 7. Division of Urology, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: pchang@bidmc.harvard.edu.
Abstract
PURPOSE: We expanded the clinical usefulness of EPIC-CP (Expanded Prostate Cancer Index Composite for Clinical Practice) by evaluating its responsiveness to health related quality of life changes, defining the minimally important differences for an individual patient change in each domain and applying it to a sexual outcome prediction model. MATERIALS AND METHODS: In 1,201 subjects from a previously described multicenter longitudinal cohort we modeled the EPIC-CP domain scores of each treatment group before treatment, and at short-term and long-term followup. We considered a posttreatment domain score change from pretreatment of 0.5 SD or greater clinically significant and p ≤ 0.01 statistically significant. We determined the domain minimally important differences using the pooled 0.5 SD of the 2, 6, 12 and 24-month posttreatment changes from pretreatment values. We then recalibrated an EPIC-CP based nomogram model predicting 2-year post-prostatectomy functional erection from that developed using EPIC-26. RESULTS: For each health related quality of life domain EPIC-CP was sensitive to similar posttreatment health related quality of life changes with time, as was observed using EPIC-26. The EPIC-CP minimally important differences in changes in the urinary incontinence, urinary irritation/obstruction, bowel, sexual and vitality/hormonal domains were 1.0, 1.3, 1.2, 1.6 and 1.0, respectively. The EPIC-CP based sexual prediction model performed well (AUC 0.76). It showed robust agreement with its EPIC-26 based counterpart with 10% or less predicted probability differences between models in 95% of individuals and a mean ± SD difference of 0.0 ± 0.05 across all individuals. CONCLUSIONS: EPIC-CP is responsive to health related quality of life changes during convalescence and it can be used to predict 2-year post-prostatectomy sexual outcomes. It can facilitate shared medical decision making and patient centered care.
PURPOSE: We expanded the clinical usefulness of EPIC-CP (Expanded Prostate Cancer Index Composite for Clinical Practice) by evaluating its responsiveness to health related quality of life changes, defining the minimally important differences for an individual patient change in each domain and applying it to a sexual outcome prediction model. MATERIALS AND METHODS: In 1,201 subjects from a previously described multicenter longitudinal cohort we modeled the EPIC-CP domain scores of each treatment group before treatment, and at short-term and long-term followup. We considered a posttreatment domain score change from pretreatment of 0.5 SD or greater clinically significant and p ≤ 0.01 statistically significant. We determined the domain minimally important differences using the pooled 0.5 SD of the 2, 6, 12 and 24-month posttreatment changes from pretreatment values. We then recalibrated an EPIC-CP based nomogram model predicting 2-year post-prostatectomy functional erection from that developed using EPIC-26. RESULTS: For each health related quality of life domain EPIC-CP was sensitive to similar posttreatment health related quality of life changes with time, as was observed using EPIC-26. The EPIC-CP minimally important differences in changes in the urinary incontinence, urinary irritation/obstruction, bowel, sexual and vitality/hormonal domains were 1.0, 1.3, 1.2, 1.6 and 1.0, respectively. The EPIC-CP based sexual prediction model performed well (AUC 0.76). It showed robust agreement with its EPIC-26 based counterpart with 10% or less predicted probability differences between models in 95% of individuals and a mean ± SD difference of 0.0 ± 0.05 across all individuals. CONCLUSIONS:EPIC-CP is responsive to health related quality of life changes during convalescence and it can be used to predict 2-year post-prostatectomy sexual outcomes. It can facilitate shared medical decision making and patient centered care.
Authors: Florian R Schroeck; Craig F Donatucci; Emily C Smathers; Leon Sun; David M Albala; Thomas J Polascik; Judd W Moul; Tracey L Krupski Journal: Cancer Date: 2008-11-15 Impact factor: 6.860
Authors: Christina Lewicky-Gaupp; John T Wei; John O L Delancey; Dee E Fenner; Edward J McGuire; Daniel M Morgan Journal: Am J Obstet Gynecol Date: 2008-10-30 Impact factor: 8.661
Authors: Matthew Eric Hyndman; Trinity J Bivalacqua; Lynda Z Mettee; Li-Ming Su; Bruce J Trock; Christian P Pavlovich Journal: Can Urol Assoc J Date: 2015-11-09 Impact factor: 1.862
Authors: Ted A Skolarus; Rodney L Dunn; Martin G Sanda; Peter Chang; Thomas K Greenfield; Mark S Litwin; John T Wei Journal: Urology Date: 2015-01 Impact factor: 2.649
Authors: Talya Salz; Shrujal S Baxi; Nirupa Raghunathan; Erin E Onstad; Andrew N Freedman; Chaya S Moskowitz; Susanne Oksbjerg Dalton; Karyn A Goodman; Christoffer Johansen; Matthew J Matasar; Peter de Nully Brown; Kevin C Oeffinger; Andrew J Vickers Journal: Eur J Cancer Date: 2015-02-27 Impact factor: 9.162
Authors: Patricia A Parker; John W Davis; David M Latini; George Baum; Xuemei Wang; John F Ward; Deborah Kuban; Steven J Frank; Andrew K Lee; Christopher J Logothetis; Jeri Kim Journal: BJU Int Date: 2015-04-21 Impact factor: 5.588
Authors: Rahul Khairnar; Lyudmila DeMora; Howard M Sandler; W Robert Lee; Ester Villalonga-Olives; C Daniel Mullins; Francis B Palumbo; Deborah W Bruner; Fadia T Shaya; Soren M Bentzen; Amit B Shah; Shawn Malone; Jeff M Michalski; Ian S Dayes; Samantha A Seaward; Michele Albert; Adam D Currey; Thomas M Pisansky; Yuhchyau Chen; Eric M Horwitz; Albert S DeNittis; Felix Feng; Mark V Mishra Journal: JCO Clin Cancer Inform Date: 2022-06
Authors: David K Jenkins; Gregory P Swanson; Sameer G Jhavar; Kristofer R Wagner; Chul S Ha; Wencong Chen Journal: Rep Pract Oncol Radiother Date: 2020-04-16